RedHill Biopharma Ltd (RDHL)

[midastouch017]

I should note that there is an upside scenario here. I think chances are low, but RedHill could receive FDA approval for Crohn's disease based on the single phase 3 trial, or perhaps accelerated approval with the obligation to do a post-marketing study. This is not something I would base my investment thesis on, but a scenario that could be possible with the “new FDA” as they call it under Dr. Gottlieb. In this case, RedHill’s CEO Ben-Asher is celebrated as a genius.